Handelsbanken Fonder AB Buys 3,700 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Handelsbanken Fonder AB lifted its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 20.6% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 21,700 shares of the company’s stock after purchasing an additional 3,700 shares during the quarter. Handelsbanken Fonder AB’s holdings in Privia Health Group were worth $395,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. SG Americas Securities LLC raised its position in shares of Privia Health Group by 732.5% in the 3rd quarter. SG Americas Securities LLC now owns 57,541 shares of the company’s stock valued at $1,048,000 after buying an additional 50,629 shares in the last quarter. Cetera Investment Advisers lifted its stake in Privia Health Group by 2.8% during the second quarter. Cetera Investment Advisers now owns 59,696 shares of the company’s stock worth $1,038,000 after purchasing an additional 1,636 shares during the last quarter. Creative Planning boosted its holdings in shares of Privia Health Group by 54.6% in the 2nd quarter. Creative Planning now owns 20,445 shares of the company’s stock valued at $355,000 after purchasing an additional 7,217 shares in the last quarter. Millennium Management LLC increased its stake in shares of Privia Health Group by 2,994.2% in the 2nd quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock valued at $19,788,000 after purchasing an additional 1,101,730 shares during the last quarter. Finally, Squarepoint Ops LLC acquired a new position in shares of Privia Health Group during the 2nd quarter worth $417,000. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Performance

Shares of NASDAQ:PRVA opened at $17.76 on Tuesday. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $24.35. The business’s 50 day simple moving average is $18.87 and its two-hundred day simple moving average is $18.32. The firm has a market cap of $2.12 billion, a P/E ratio of 118.40, a PEG ratio of 3.93 and a beta of 0.76.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. The business had revenue of $422.30 million for the quarter, compared to the consensus estimate of $411.50 million. During the same quarter last year, the firm posted $0.06 EPS. The business’s revenue for the quarter was up 2.2% compared to the same quarter last year. On average, equities analysts forecast that Privia Health Group, Inc. will post 0.16 earnings per share for the current fiscal year.

Insider Buying and Selling at Privia Health Group

In other news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the transaction, the chief executive officer now owns 247,771 shares in the company, valued at $4,583,763.50. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 14.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on PRVA. Robert W. Baird lifted their target price on Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, August 26th. KeyCorp initiated coverage on shares of Privia Health Group in a research report on Friday. They issued an “overweight” rating and a $23.00 target price on the stock. Royal Bank of Canada reiterated an “outperform” rating and issued a $28.00 price target on shares of Privia Health Group in a research note on Wednesday, August 14th. Finally, Evercore ISI cut their price target on Privia Health Group from $23.00 to $20.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 9th. Two equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Privia Health Group has a consensus rating of “Buy” and a consensus target price of $24.73.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.